Increasing challenges to trial recruitment: Is it time to change the inclusion criteria for investigational compounds, not just for study participants?

Epilepsia. 2024 May 7. doi: 10.1111/epi.17978. Online ahead of print.

Authors

Amit David Eyal¹, Sara Eyal²

Affiliations

¹ Hebrew University of Jerusalem, Jerusalem, Israel.
² Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

PMID: 38713479
DOI: 10.1111/epi.17978

No abstract available

Keywords: candidate screening; clinical trials; desirability score; drug design; structure–activity relationships.